Display options
Cite
D'haeseleer E, Van Lierde K, Claeys S, et al. The impact of menopause and hormone therapy on voice and nasal resonance. Facts Views Vis Obgyn. 2012;4(1):38-41
D'haeseleer, E., Van Lierde, K., Claeys, S., & Depypere, H. (2012). The impact of menopause and hormone therapy on voice and nasal resonance. Facts, views & vision in ObGyn, 4(1), 38-41.
D'haeseleer, E, et al. "The impact of menopause and hormone therapy on voice and nasal resonance." Facts, views & vision in ObGyn vol. 4,1 (2012): 38-41.
D'haeseleer E, Van Lierde K, Claeys S, Depypere H. The impact of menopause and hormone therapy on voice and nasal resonance. Facts Views Vis Obgyn. 2012;4(1):38-41. PMID: 24753887; PMCID: PMC3991439.
Copy Download .nbib Format: NLM
Share it on

Facts Views Vis Obgyn. 2012;4(1):38-41.

The impact of menopause and hormone therapy on voice and nasal resonance.

Facts, views & vision in ObGyn

E D'haeseleer, K Van Lierde, S Claeys, H Depypere

Affiliations

  1. Logopaedic and Audiologic Sciences & Otorhinolaryngology, Ghent University, Belgium.
  2. Gynaecologie, Ghent University, Belgium.

PMID: 24753887 PMCID: PMC3991439

Abstract

In an initial study it was shown that (without hormonal influences) middle-aged (premenopausal) women show a smaller frequency and intensity range and a lower fundamental frequency of the voice compared to young women. To investigate the impact of menopause on voice and nasal resonance a cross-sectional non-randomized study design was used. Vocal characteristics and nasal resonance in premenopausal and postmenopausal women without hormone therapy (HT) were compared. Postmenopausal women without HT showed a significantly lower speaking fundamental frequency (SFF) and were able to phonate lower compared to postmenopausal women with HT. The mean difference in SFF was 14 Hz. HT can also counteract the menopausal changes in SFF. The lower SFF did not result in vocal complaints. Further research about the impact of menopause and HT on voice should concentrate on elite professional voice users.

Keywords: BMI; hormone therapy; nasal resonance; postmenopausal; premenopausal; voice

References

  1. J Voice. 2008 Jul;22(4):399-407 - PubMed
  2. World Health Organ Tech Rep Ser. 1996;866:1-107 - PubMed
  3. Maturitas. 1997 Sep;28(1):47-53 - PubMed
  4. J Voice. 2011 May;25(3):360-6 - PubMed
  5. J Clin Endocrinol Metab. 2004 Apr;89(4):1555-61 - PubMed
  6. J Voice. 2010 May;24(3):363-8 - PubMed
  7. Maturitas. 2004 May 28;48(1):71-7 - PubMed
  8. Hear Res. 2003 Aug;182(1-2):153-63 - PubMed
  9. Menopause. 2010 Jul;17(4):718-26 - PubMed
  10. Ann Otol Rhinol Laryngol. 2011 Sep;120(9):575-80 - PubMed
  11. Menopause. 2011 Mar;18(3):267-72 - PubMed
  12. J Voice. 1999 Sep;13(3):424-46 - PubMed
  13. Exp Gerontol. 1994 May-Aug;29(3-4):479-93 - PubMed
  14. Br J Disord Commun. 1983 Dec;18(3):139-51 - PubMed
  15. Fertil Steril. 2000 Dec;74(6):1073-9 - PubMed
  16. J Voice. 2004 Sep;18(3):369-74 - PubMed

Publication Types